Results 211 to 220 of about 340,370 (339)
Advanced therapy in familial hypercholesterolemia. [PDF]
Gao E, Brunham LR, Goldman RD.
europepmc +1 more source
ABSTRACT Objectives Recent clinical studies have suggested that glucagon‐like peptide‐1 receptor (GLP‐1R) agonists may be effective therapies to treat or reduce the risk of developing secondary lymphedema. In this study, we aimed to (1) determine if GLP‐1Rs are present in the lymphatic vasculature and characterize their expression, and (2) assess the ...
Mary E. Schulz +3 more
wiley +1 more source
Familial Hypercholesterolemia in Women: Diagnosis, Treatment, and Cardiovascular Outcomes Across the Lifespan. [PDF]
Karungi I +3 more
europepmc +1 more source
ABSTRACT This systematic review and meta‐analysis of randomized controlled trials (RCTs) was conducted to assess the effect of nutraceuticals containing Citrus bergamia on the management of obesity in adults by assessing measures related to obesity. We searched the following databases until October 2024: PubMed, Web of Science, Scopus, and the Cochrane
Carmelo Pujia +8 more
wiley +1 more source
Positive Predictive Values of Familial Hypercholesterolemia Diagnoses in the Danish National Patient Registry and the Danish Familial Hypercholesterolemia Registry - A Validation Study. [PDF]
Knold J +24 more
europepmc +1 more source
ABSTRACT Background The association between adverse childhood experiences (ACEs) and metabolic syndrome (MetS) across life course and its components (abdominal obesity, elevated blood pressure, dyslipidemia, and hyperglycemia) is poorly understood. Methods Three databases were screened for studies published January 2000–February 2024 that examined the ...
Joohan Kim +4 more
wiley +1 more source
Familial Hypercholesterolemia Presenting With Joint Pain in an Adolescent Girl. [PDF]
Potla C, Jeevarathnam D, Janarthanan M.
europepmc +1 more source
Homozygous familial hypercholesterolemia
We report a rare case of homozygous familial hypercholesterolemia (HoFH), a 22-year-old Malay woman who presented initially with minor soft tissue injury due to a cycling accident.
Siti Ayuni Binti Zakyudin
core
Context‐Dependent Effects of Apolipoprotein A2 on Lipid Metabolism and Atherogenesis
Proposed model of the pro‐atherogenic role of APOA2 in dyslipidemia. Under conditions of dyslipidemia (ldlr−/− and apoe−/− mice), APOA2 promotes a reduction in VLDL through its conversion to LDL via an LDLR‐independent pathway. LDL is then deposited to the aorta and aortic root. In the ldlr−/− mice, the presence of APOE may mitigate the rate of VLDL to
Evangelia Zvintzou +9 more
wiley +1 more source
Genetic screening and response to drug therapy in familial hypercholesterolemia. [PDF]
Lu Y, Chen Q, Zhang W, Dong J, Zha L.
europepmc +1 more source

